SIOUX FALLS, S.D., July 24, 2017 /PRNewswire/ -- Vance Thompson Vision, a refractive surgery and research facility specializing in refractive cataract surgery and laser vision correction, will be the first center in the United States to utilize Zepto in conjunction with Refractive Laser-Assisted Cataract Surgery, or ReLACS. This technology uses low-energy pulses to create a precise capsulotomy, independent of pupile size, corneal clarity or lens density.
Dr. Vance Thompson, a refractive surgeon at Vance Thompson Vision in Sioux Falls, says that Zepto will provide more options to his patients.
"Zepto results in a strong capsulotomy," says Dr. Thompson. "It provides fewer logistical challenges during the surgery and reduces the overall time the patient spends in surgery."
US-based medical device company Mynosys have developed the Zepto capsulotomy system for creating a round, regular and strong incision in the clear lens capsule that surrounds the crystalline lens. A round opening in this capsule must be made during cataract surgery to allow access to and removal of the cloudy lens material beneath. Electrical pulses are delivered to create the capsulotomy, which results in no cautery or burning of tissue.
Dr. Thompson is a clinical investigator for the United States clinical trials that are currently underway. His first case with the Zepto technology will be on Monday, July 24th.
"The Zepto device is an innovative system that will provide reliable, reproducible and automated incisions during cataract surgery," says Dr. Thompson. We are excited to be able to bring this option to patients and offer them continued options for visual freedom."
About Vance Thompson VisionVance Thompson Vision, Sioux Falls, SD and Fargo, ND, is a world-class refractive surgery center and research institute. Vance Thompson Vision provides and participates in developing the world's most exceptional technologies to improve outcomes in surgical care; all while creating a patient experience that is second to none. With more than 100,000 procedures, more than 80 FDA monitored clinical trials, and having traveled the world to advance the learning of providers everywhere, Vance Thompson Vision is the standard in quality and innovation. For more information on the international reputation of the doctors that lead studies such as this one visit the biographies of Dr. Vance Thompson, Dr. Alison Tendler, Dr. John Berdahl, Dr. Michael Greenwood, Dr. Russell Swan, Dr. Doug Wallin, Dr. Keith Rasmussen, Dr. Justin Schweitzer, Dr. Jason Schmit, and Dr. Mitch Ibach.
Contact:
Matt Jensen
CEO: Sioux Falls, SD
(605) 371-7120 or (605) 351-8933 / [email protected]
Advertisement
Dr. Vance Thompson, a refractive surgeon at Vance Thompson Vision in Sioux Falls, says that Zepto will provide more options to his patients.
Advertisement
"Zepto results in a strong capsulotomy," says Dr. Thompson. "It provides fewer logistical challenges during the surgery and reduces the overall time the patient spends in surgery."
US-based medical device company Mynosys have developed the Zepto capsulotomy system for creating a round, regular and strong incision in the clear lens capsule that surrounds the crystalline lens. A round opening in this capsule must be made during cataract surgery to allow access to and removal of the cloudy lens material beneath. Electrical pulses are delivered to create the capsulotomy, which results in no cautery or burning of tissue.
Dr. Thompson is a clinical investigator for the United States clinical trials that are currently underway. His first case with the Zepto technology will be on Monday, July 24th.
"The Zepto device is an innovative system that will provide reliable, reproducible and automated incisions during cataract surgery," says Dr. Thompson. We are excited to be able to bring this option to patients and offer them continued options for visual freedom."
About Vance Thompson VisionVance Thompson Vision, Sioux Falls, SD and Fargo, ND, is a world-class refractive surgery center and research institute. Vance Thompson Vision provides and participates in developing the world's most exceptional technologies to improve outcomes in surgical care; all while creating a patient experience that is second to none. With more than 100,000 procedures, more than 80 FDA monitored clinical trials, and having traveled the world to advance the learning of providers everywhere, Vance Thompson Vision is the standard in quality and innovation. For more information on the international reputation of the doctors that lead studies such as this one visit the biographies of Dr. Vance Thompson, Dr. Alison Tendler, Dr. John Berdahl, Dr. Michael Greenwood, Dr. Russell Swan, Dr. Doug Wallin, Dr. Keith Rasmussen, Dr. Justin Schweitzer, Dr. Jason Schmit, and Dr. Mitch Ibach.
Contact:
Matt Jensen
CEO: Sioux Falls, SD
(605) 371-7120 or (605) 351-8933 / [email protected]
View original content:http://www.prnewswire.com/news-releases/vance-thompson-vision-first-in-the-united-states-to-perform-cataract-surgery-with-zepto-300493236.html
SOURCE Vance Thompson Vision
